Stratification and prevention of the risk of arrhythmia in nonischemic dilatation cardiomyopathy;Stratificazione e prevenzione del rischio aritmico nella cardiomiopatia dilatativa non ischemica

Giornale Italiano di Cardiologia

Volumn 28, Issue 11, 1998, Pages 1288-1302

  Ansalone, Gerardo ^a,b   Giannantoni, Paride ^a   Santini, Massimo ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Arrhythmias; Dilated cardiomyopathy

Indexed keywords

DISEASE SEVERITY; HEART ARRHYTHMIA; HEART DEATH; HEART DILATATION; HUMAN; LIFE EXPECTANCY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SUDDEN DEATH;

ARRHYTHMIA; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; HUMANS; INCIDENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 0031760373     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. BIGGER JT JR: Why patients with congestive heart failure die: arrythmias and sudden cardiac death. Circulation 1987; 75 (Suppl 4, pt2): IV-28-IV-35.
2. THE SOLVD INVASTIGATORS: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691.
3. GRADMAN A, DEEDWANIA P, CODY R, ET AL: Predictors of total mortality and sudden death in mild to moderate heart failure: Captopril Digoxin Study Group. J Am Coll Cardiol 1989; 14: 564-570.
4. COHN JN, JOHNSON G, ZIESCHE S, ET AL: A comparison of enalapril with hydralazine-isosordide in treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-310.
5. THE CONSENSUS TRIAL STUDY GROUP: Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
6. THE SOLVD INVESTIGATORS: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
7. CIBIS INVESTIGATORS AND COMMITTEES: A randomized trial of beta-blockade in heart failure. The cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994; 90: 1765-1773.
8. WAAGSTEIN F, BRISTOW MR, SWEDBERG K, ET AL: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: metoprolol in dilated cardiomyopathy (MDC) trial study group. Lancet 1993; 342: 1441-1446.
9. PACKER M, BRISTOW MR, COHN JN, ET AL: The effect of carvedilol. on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
10. BRISTOW MR, GILBERT EM, ABRAHAM WT ET AL, FOR THE MOCHA INVESTIGATORS: Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996; 94: 2807-2816.
11. HEIDENREICH PA, LEE TT, MASSIE BM: Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997; 30: 27-34.
12. DOUGHTY RN, RODGERS A, SHARPE N, MACMAHON S: Effects of beta-blocker therapy on mortality in patients with heart failure. Eur Heart J 1997; 18: 560-565.
13. DEEDWANIA PC: Ventricular arrythmias in heart failure: to treat or not treat? Cardiol Clin 1994; 12: 115-132.
14. WYSE DG, MORGANROTH J, HALLSTROM A, ET AL: Analysis of early ventricular proarrhythia in the Cardiac Arrhyhmia Suppression Trial (CAST) (abstract). J Am Coll Cardiol 1992; 19: 77A.
15. SINGH SN, FLETCHER RD, FISHER SG, ET AL: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
16. WALDO AL, CAMM AS, DERUYTER H, ET AL: Effect od d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-sotalol. Lancet 1996; 348: 7-12.
17. DOVAL HC, NUL DR, GRANCELLI HO, PERRONR SV, BORTMAN GR, CURIEL R: Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-498.
18. NICKLAS JM, MCKENNA WJ, STEWART RA, ET AL: Prospective, double-blind, placebo-controlled trial of low dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 1991; 122: 1016-1021.
19. COSTANZO MR, AUGUSTINE C, BOURGE R, ET AL: Selection and treatment of candidates for heart transplantation. A statement for health professionals from the committee on heart failure and cardiac transplantation of the council on clinical cardiology, AHA. Circulation 1995; 92: 3593-3612.
20. CAIRNS JA, CONNOLLY SJ, ROBERTS R, GENT M: Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisation: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997; 349: 675-682.
21. JULIAN DG, CAMM AJ, FRANGIN G, ET AL: Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997; 349: 667-674.
22. Moss A, HALL J, CANNOM D, ET AL: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. MADIT. N Engl J Med 1996; 335: 1933-1940.
23. GOLDMAN S, JOHNSON G, COHN JN, CINTRON G, SMITH R, FRANCIS G FOR THE V-HEFT VA: Mechanism of death in heart failure. The vasodilator-heart failure trials. Circulation 1993; 87: VI-24-VI-31.
24. COHN JN, ARCHIBALD DG, ZIESCHE S, ET AL: Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a veterans administration cooperative study. N Engl J Med 1986; 314: 1547-1552.
25. FRANCIS GS, COHN JN, JOHNSON G, RECTOR TS, GOLDMAN S, SIMON A FOR THE V-HEFT VA: Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II: The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: VI-40-VI-48.
26. SAXON LA, STEVENSON WG, MIDDLEKAUFF HR, ET AL: Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1993; 72: 62-65.
27. PINSKY DJ, SCIACCA RR, STEINBERG JS: QT dispersion as a marker of risk in patients awaiting heart transplantation. J Am Coll Cardiol 1997; 29: 1576-1584.
28. LEE TH, HAMILTON MA, STEVENSON LW, ET AL: Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 1993; 72: 672-676.
29. MIDDLEKAUFF HR, STEVENSON WG, STEVENSON LW: Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991; 84: 40-48.
30. DAS SK, MORADY F, DICARLO L JR, ET AL: Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyophaty without symptomatic ventricular arrhythmias. Am J Cardiol 1986; 58: 998-1000.
31. BAYES DE LUNA A, COUMEL P, LECLERCQ JF: Ambulatory sudden cardiac death: mechanisms of production of arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117: 151-159.
32. WILBER D, GARAN H, FINKELSTEIN D, ET AL: Out-of-hospital cardiac arrest: use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988; 318: 19-24.
33. Luu M, STEVENSON WG, STEVENSON LW, BARON K, WALDEN J: Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989; 80: 1675-1680.
34. STEVENSON WG, STEVENSON LW, MIDDLEKAUFF HR, SAXON LA: Sudden death prevention in patients with advanced heart failure. Circulation 1993; 88: 2953-2961.
35. FUSTER V, GERSH BJ, GIULIANI ER, TAJIK AJ, BRANDENBURG RO, FRYE RL: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-531.
36. FUSTER V, STEIN B, HALPERIN JL, CHESEBRO JH: Antithrombotic therapy in cardiac disease: an approach based on pathogenesis and risk stratification. Am J Cardiol 1990; 65: 38C-44C.
37. TSEVAT J, ECKMAN MH, MCNUTT RA, PAUKER SG: Warfarin for dilated cardiomyopathy: a bloody tough pill to swallow? Med Decis Making 1989; 9: 162-169.
38. HENDERSON EB, KAHN JK, CORBETT JR, ET AL: Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192-1199.
39. CALKINS H, ALLMAN K, BULLING S, ET AL: Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart. Circulation 1993; 88: 172-179.
40. Kuo C-S, MUNAKATA K, REDDY CP, SURAWICZ B: Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983; 67: 1356-1367.
41. VASSALLO JA, CASSIDY MD, KINDWALL E, MARCHLINSKI FE, JOSEPHSON ME: Nonuniform recovery of excitability in the left ventricle. Circulation 1988; 78: 1365-1372
42. TOMASELLI GF, BEUCKELMANN DJ, CALKINS HG, ET AL: Sudden cardiac death in heart failure. Circulation 1994; 90: 2534-2539.
43. COHN JN, ARCHIBALD DG, FRANCIS GS, ET AL: Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on reduction of mortality by treatment with hydralazine and isosorbide dinitrate. Circulation 1987; 75 (Suppl 4, pt 2): IV-49-IV-54.
44. DEC GW, FIFER MA, HERRMANN HC, COCCA-SPOFFORD D, SEMIGRAN MJ: Long-term outcome of enoximone theraphy in patients with refractory heart failure. Am Heart J 1993; 125: 423-429.
45. MANCINI DM, EISEN H, KUSSMAUL W, MULL R, EDMUNDS LH JR, WILSON JR: Value of peak exercise oxigen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-786.
46. STEVENSON LW, TILLISCH JH, HAMILTON M, ET AL: Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990; 66: 1348-1354.
47. FRANCIOSA JA: Why patients with heart failure die: hemodynamic and functional determinants of survival. Circulation 1987; 75 (Suppl 4, pt 2): IV-20-IV-27.
48. MUDGE GH, GOLDESTEIN S, ADDONIZIO, ET AL: Twenty-fourth Bethesda conference: cardiac transplantation. Task Force 3: recipient guidelines/prioritization. Am J Cardiol 1993; 22: 21-31.
49. COHN JN, LEVINE TB, OLIVARI MT, ET AL: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823.
50. STEELE IC, MCDOWELL G, MOORE A, ET AL: Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Invest 1997; 27: 270-276.
51. Yu CM, SANDERSON JE, SHUM IO, ET AL: Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996; 17: 1694-1702.
52. KEOGH AM, BARON DW, HICKIE JB: Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for heart transplantation. Am J Cardiol 1990; 65: 903-908.
53. ROCKMAN H, JUNEAU C, CHATTERJEE K, ROULEAU J: Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1989; 64: 1344-1348.
54. GRADMAN AH, DEEDWANIA PC: Predictors of mortality in patients with heart failure. Cardiol Clin 1994; 12: 25-35.
55. GRIFFIN BP, SHAH PK, FERGUSON J, RUBIN SA: Incremental prognostic value of exercise hemodymanic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cardiol 1991; 67: 848-853.
56. LEE WH, PACKER M: Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73: 257-267.
57. ANGUITA M, ARIZON JM, BUOENO G, ET AL: Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1993; 72: 413-417.
58. LAMPERT S, LOWN B, GRABOYS T, PODRID P, BLATT C: Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease. Am J Cardiol 1988; 61: 791-797.
59. POLL DS, MARCHLINSKI FE, FALCONE RA, JOSEPHSON ME, SIMSON MB: Abnormal signal averaged electrocardiograms in patients with non-ischemic congestive cardiomyopathy: relationship to sustained ventricular tachyarrhythmias. Circulation 1985; 72: 1308-1313.
60. OHNISHI Y, INOUE T, FUKUZAKI H: Value of the signal averaged electrocardiogram as a predictor of sudden death in myocardial infarction and dilated cardiomyopathy. Jpn Circ J 1990; 54: 127-136.
61. TURITTO G, AHUJA RK, BEKHEIT S, CAREF EB, IBRAHIM B, EL-SHERIF N: Incidence and prediction of induced ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 73: 770-773.
62. MANCINI DM, WONG KL, SIMSON MB: Prognostic value of an abnormal signal-averaged electrocardiogram in patients with non-ischemic congestive cardiomyopathy. Circulation 1993; 87: 1083-1092.
63. TURITTO G, FONTAINE JM, URSELL SN, CAREF EB, HENKIN R, EL-SHERIF N: Value of the signal-averaged electrocardiogram as a predictor of the results of programmed stimulation in nonsustained ventricular tachycardia. Am J Cardiol 1988; 61: 1272-1278.
64. KEELING PJ, KULAKOWSKI P, YI G, SLADE AKB, BENT S, MCKENNA WJ: Usefulness of signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy for identifying patients with ventricular arrhythmias. Am J Cardiol 1993; 72: 78-84.
65. SILVERMAN ME, PRESSEL MD, BRACKETT JC, LAURIA SS, GOLD MR, GOTTLIEB SS: Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol 1995; 75: 460-464.
66. MIDDLEKAUFF HR, STEVENSON WG, WOO MA, MOSER DK, STEVENSON LW: Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and then usefulness in predicting sudden death. Am J Cardiol 1990; 66: 1113-1117.
67. LINDSAY BD, OSBORN JL, KENNETH BS, KENZORA JL, AMBOS HD, CAIN ME: Prospective detection of vulnerability to sustained ventricular tachycardia in patients awaiting cardiac transplantation. Am J Cardiol 1992; 69: 619-624.
68. ANSALONE G, AURITI A, PANDOZI C, ET AL: SAECG in dilated cardiomyopathy: a comparison of time and frequency criteria (abstract). PACE 1995; 18 (5 pt II): 1109.
69. FONTAINE JM, RAO R, HENKIN R, SUNEJA R, URSELL SN, EL-SHERIF N: Study of the influence of left bundle branch block on the signal-averaged electrocardiogram: a quantitative analysis. Am Heart J 1991; 121: 494-508.
70. CAREF EB, TURITTO G, IBRAHIM BB, HENKIN R, EL-SHERIF N: Role of band-bass filters in optimizing the value of the signal-averaged electrocardiogram as a predictor of the results of programmed stimulation. Am J Cardiol 1989; 64: 16-26.
71. HABERL R, JILGE G, PULTER R, STEINBECK G: Spectral mapping of the electrocardiogram with Fourier transform for identification of patients with sustained ventricular tachycardia and coronary artery disease. Eur Heart J 1989; 10: 316-322.
72. GALINIER M, ALBENGUE JP, AFCHAR N, ET AL: Prognostic value of late potentials in patients with congestive heart failure. Eur Heart J 1996; 17: 264-271.
73. YI G, KEELING PJ, GOLDMAN JH, JIAN H, POLONIECKI J, MCKENNA WJ: Prognostic significance of spectral turbulence analysis of the signal-averaged electrocardiogram in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1995; 75: 494-497.
74. SAUL JP, REA RF, ECKBERG DL, BERGER RD, COHEN RJ: Heart rate and muscle sympathetic nerve variability during reflex changes of autonomic activity. Am J Physiol 1990; 258: H713-H721.
75. CARUANA MP, LAHIRI A, CASHMAN PM, ALTMAN DG, RAFTERY EB: Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. Am J Cardiol 1988; 62: 755-759.
76. KIENZLE MG, FERGUSON DW, BIRKETT CL, MYERS GA, BERG WJ, MARIANO DJ: Clinical hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 1992; 69: 761-767.
77. Woo MA, MOSER DK, STEVENSON WG: Comparison of 3 methods of heart rate variability analysis. Circulation 1991; 84: II-471.
78. KLEIGER RE, MILLER JP, BIGGER JT, Moss AJ: Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-262.
79. KUHN WF, MYERS B, BRENNAN AF, ET AL: Psichopatology in heart transplant candidates. J Heart Transplant 1988; 7: 223-226.
80. FRIERSON RL, LIPPMANN SB: Heart transplant candidates rejected on psychiatric indications. Psychosomatics 1987; 28: 347-355.
81. PHIPPS L: Psychiatric aspects of heart transplantation. Can J Psychiatry 1991; 36: 563-568.
82. Woo MA, STEVENSON WG, MOSER DK: Elevated serum catecholamines and Poincarè plots. Circulation 1992; 86: I-106.
83. NOLAN JP, BATIN PD, LINDSAY SJ, ET AL: Reduced heart rate variability and mortality in chronic heart failure (abstract). Circulation 1996; 94: I-498/2921.
84. YI G, GOLDMAN J, KEELING P, REARDON M, MALIK M: Assessment of heart rate variability in idiopathic dilated cardiomyopathy (abstract). Circulation 1996; 94: I-498/2919.
85. MORTARA A, LA ROVERE MT, PINNA GD, ET AL: Arterial baroreflex modulation of heart rate in chronic heart failure. Clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450-3458.
86. BREMBILLA-PERROT, DONETTI J, TERRIER DE LA CHAISE A, SADOUL N, ALIOT E, JUILLIERE Y: Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991; 121: 1124-1131.
87. BORGGREFE M, CHEN X, BLOCK M, ET AL: The role of the ICD in patients with dilated and hypertrophic cardiomyopathy. PACE 1992; 15: 616-626.
88. CHEN X, SHENASA M, BORGGREFE M, ET AL: Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. Eur Heart J 1994; 15: 76-82.
89. RAE AP, SPIELMAN SR, KUTALEK SP, KAY HR, HOROWITZ LN: Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy. Am J Cardiol 1987; 59: 291-295.
90. LIEM LB, SWERDLOW CD: Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Am J Cardiol 1988; 62: 611-616.
91. MILNER PG, DIMARCO JP, LERMAN BB: Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. PACE 1988; 11: 562-568.
92. BORGGREFE M, CHEN X, MARTINEZ-RUBIO A, ET AL: The role of implantable cardioverter defibrillators in dilated cardiomyopathy. Am Heart J 1994; 127: 1145-1150.
93. KUCK KH: Prospective studies assessing prophylactic therapy in high risk patients: the German Dilated Cardiomyopathy Study - Study Design. PACE 1992; 15: 697-700.
94. TORRES V, FLOWERS D, SOMBERG JC: The arrhythmogenicity of antiarrhythmic agents. Am Heart J 1985; 109 (pt 1): 1090-1097.
95. DOVAL HC, NUL DR, GRANCELLI HO, PERRONE SV, BORTMAN GR, CURIEL R: Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-498.
96. NICKLAS JM, MCKENNA WJ, STEWART RA, ET AL: Prospective, double blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 1991; 122 (pt1): 1016-1021.
97. PODRID PJ, FOGEL RI, FORDJMAN-FUCHS T: Arrhythmias in patients with a cardiomyopathy and congestive heart failure. In: HOSENPUD JD, GREENBERG BH (eds): Congestive heart failure: pathophysiology, diagnosis and comprehensive approach to management. New York, Springer-Verlag, 1994, 645-686.
98. FOGOROS RS, ELSON JJ, BONNET CA, FIELDER SB, BURKHOLDER JA: Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990; 16: 381-386.
99. GEHA AS, ELEFTERIADES JA, HSU J, ET AL: Strategies in the surgical treatment of malignant ventricular arrhythmias: an 8-year experience. Ann Surg 1992; 216: 309-316.
100. WILBER DJ, OLSHANSKY B, MORAN JF, SCANLON PJ: Electrophysiological testing and nonsustained ventricular tachycardia: use and limitation in patients with coronary artery disease and impaired ventricular function. Circulation 1990; 82: 350-358.